Autor:

Patel ZM, Thamboo A, Rudmik L, Nayak JV, Smith TL, Hwang PH.

Ano:

2017

Publicação:

International Forum of Allergy & Rhinology, Vol. 7, No. 2, Fevereiro 2017

Introdução:

The currently accepted treatment paradigm of treating chronic rhinosinusitis (CRS) first with appropriate medical therapy (AMT) and then with surgery if patients are refractory to AMT, has been criticized for lack of evidence. The objective of this study was to reassess the literature and establish the highest level of evidence possible regarding further management of CRS patients refractory to AMT.